{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:14:53Z","timestamp":1789020893072,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nutr J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12937-016-0130-8","type":"journal-article","created":{"date-parts":[[2016,1,29]],"date-time":"2016-01-29T00:37:40Z","timestamp":1454027860000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["Efficacy and tolerability of an undenatured type II collagen supplement in modulating knee osteoarthritis symptoms: a multicenter randomized, double-blind, placebo-controlled study"],"prefix":"10.1186","volume":"15","author":[{"given":"James P.","family":"Lugo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zainulabedin M.","family":"Saiyed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,29]]},"reference":[{"issue":"1","key":"130_CR1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/art.23176","volume":"58","author":"RC Lawrence","year":"2008","unstructured":"Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II Arthritis Rheum. 2008;58(1):26\u201335. doi: 10.1002\/art.23176 .","journal-title":"Part II. Arthritis Rheum."},{"issue":"4","key":"130_CR2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/acr.21596","volume":"64","author":"MC Hochberg","year":"2012","unstructured":"Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465\u201374.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"130_CR3","unstructured":"National Institute of Health and Care Excellence; NICE clinical guideline 177. https:\/\/www.nice.org.uk\/guidance\/cg177 . accessed October 19, 2015."},{"issue":"1","key":"130_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrrheum.2010.178","volume":"7","author":"DJ Hunter","year":"2011","unstructured":"Hunter DJ. Pharmacologic therapy for osteoarthritis\u2014the era of disease modification. Nat Rev Rheumatol. 2011;7(1):13\u201322. doi: 10.1038\/nrrheum.2010.178 .","journal-title":"Nat Rev Rheumatol"},{"issue":"6","key":"130_CR5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.7150\/ijms.6.312","volume":"6","author":"DC Crowley","year":"2009","unstructured":"Crowley DC, Lau FC, Sharma P, Evans M, Guthrie N, Bagchi M, et al. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. Int J Med Sci. 2009;6(6):312\u201321.","journal-title":"Int J Med Sci"},{"issue":"3\u20134","key":"130_CR6","first-page":"101","volume":"22","author":"D Bagchi","year":"2002","unstructured":"Bagchi D, Misner B, Bagchi M, Kothari SC, Downs BW, Fafard RD, et al. Effects of orally administered undenatured type II collagen against arthritic inflammatory diseases: a mechanistic exploration. Int J Clin Pharmacol Res. 2002;22(3\u20134):101\u201310.","journal-title":"Int J Clin Pharmacol Res"},{"issue":"1","key":"130_CR7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1550-2783-10-48","volume":"10","author":"JP Lugo","year":"2013","unstructured":"Lugo JP, Saiyed ZM, Lau FC, Molina JP, Pakdaman MN, Shamie AN, et al. Undenatured type II collagen (UC-II(R)) for joint support: a randomized, double-blind, placebo-controlled study in healthy volunteers. J Int Soc Sports Nutr. 2013;10(1):48. doi: 10.1186\/1550-2783-10-48 .","journal-title":"J Int Soc Sports Nutr"},{"issue":"4","key":"130_CR8","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/ard.16.4.494","volume":"16","author":"JH Kellgren","year":"1957","unstructured":"Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis. 1957;16(4):494\u2013502.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"130_CR9","first-page":"110","volume":"3","author":"N Shah","year":"2008","unstructured":"Shah N. Increasing knee range of motion using a unique sustained method. N Am J Sports Phys Ther. 2008;3(2):110\u20133.","journal-title":"N Am J Sports Phys Ther"},{"key":"130_CR10","first-page":"33","volume":"4","author":"S Tseng","year":"2009","unstructured":"Tseng S, Reddi AH, Di Cesare PE. Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis. Biomark Insights. 2009;4:33\u201344.","journal-title":"Biomark Insights."},{"issue":"1","key":"130_CR11","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.joca.2009.07.004","volume":"18","author":"SG Petersen","year":"2010","unstructured":"Petersen SG, Saxne T, Heinegard D, Hansen M, Holm L, Koskinen S, et al. Glucosamine but not ibuprofen alters cartilage turnover in osteoarthritis patients in response to physical training. Osteoarthritis Cartilage. 2010;18(1):34\u201340. doi: 10.1016\/j.joca.2009.07.004 .","journal-title":"Osteoarthritis Cartilage"},{"issue":"11","key":"130_CR12","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1136\/annrheumdis-2013-203726","volume":"72","author":"M Lotz","year":"2013","unstructured":"Lotz M, Martel-Pelletier J, Christiansen C, Brandi ML, Bruyere O, Chapurlat R, et al. Value of biomarkers in osteoarthritis: current status and perspectives. Ann Rheum Dis. 2013;72(11):1756\u201363. doi: 10.1136\/annrheumdis-2013-203726 .","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"130_CR13","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.mri.2004.08.001","volume":"22","author":"KB King","year":"2004","unstructured":"King KB, Lindsey CT, Dunn TC, Ries MD, Steinbach LS, Majumdar S. A study of the relationship between molecular biomarkers of joint degeneration and the magnetic resonance-measured characteristics of cartilage in 16 symptomatic knees. Magn Reson Imaging. 2004;22(8):1117\u201323. doi: 10.1016\/j.mri.2004.08.001 .","journal-title":"Magn Reson Imaging"},{"issue":"5","key":"130_CR14","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.joca.2007.09.008","volume":"16","author":"RK Chaganti","year":"2008","unstructured":"Chaganti RK, Kelman A, Lui L, Yao W, Javaid MK, Bauer D, et al. Change in serum measurements of cartilage oligomeric matrix protein and association with the development and worsening of radiographic hip osteoarthritis. Osteoarthritis Cartilage. 2008;16(5):566\u201371. doi: 10.1016\/j.joca.2007.09.008 .","journal-title":"Osteoarthritis Cartilage"},{"issue":"19","key":"130_CR15","doi-asserted-by":"crossref","first-page":"7443","DOI":"10.1073\/pnas.83.19.7443","volume":"83","author":"C Nagler-Anderson","year":"1986","unstructured":"Nagler-Anderson C, Bober LA, Robinson ME, Siskind GW, Thorbecke GJ. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen. Proc Natl Acad Sci U S A. 1986;83(19):7443\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"130_CR16","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00011-009-0109-4","volume":"59","author":"T Tong","year":"2010","unstructured":"Tong T, Zhao W, Wu YQ, Chang Y, Wang QT, Zhang LL, et al. Chicken type II collagen induced immune balance of main subtype of helper T cells in mesenteric lymph node lymphocytes in rats with collagen-induced arthritis. Inflamm Res. 2010;59(5):369\u201377. doi: 10.1007\/s00011-009-0109-4 .","journal-title":"Inflamm Res"},{"key":"130_CR17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/1471-2474-14-228","volume":"14","author":"ML Cesare Di","year":"2013","unstructured":"Di Cesare ML, Micheli L, Zanardelli M, Ghelardini C. Low dose native type II collagen prevents pain in a rat osteoarthritis model. BMC Musculoskelet Disord. 2013;14:228. doi: 10.1186\/1471-2474-14-228 .","journal-title":"BMC Musculoskelet Disord."},{"issue":"3","key":"130_CR18","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1186\/ar4567","volume":"16","author":"H Asnagli","year":"2014","unstructured":"Asnagli H, Martire D, Belmonte N, Quentin J, Bastian H, Boucard-Jourdin M, et al. Type 1 regulatory T cells specific for collagen type II as an efficient cell-based therapy in arthritis. Arthritis Res Ther. 2014;16(3):R115. doi: 10.1186\/ar4567 .","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"130_CR19","doi-asserted-by":"crossref","first-page":"899","DOI":"10.4049\/jimmunol.181.2.899","volume":"181","author":"F Broere","year":"2008","unstructured":"Broere F, Wieten L, Klein Koerkamp EI, van Roon JA, Guichelaar T, Lafeber FP, et al. Oral or nasal antigen induces regulatory T cells that suppress arthritis and proliferation of arthritogenic T cells in joint draining lymph nodes. J Immunol. 2008;181(2):899\u2013906.","journal-title":"J Immunol"},{"issue":"1","key":"130_CR20","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-065X.2011.01017.x","volume":"241","author":"HL Weiner","year":"2011","unstructured":"Weiner HL, da Cunha AP, Quintana F, Wu H. Oral tolerance. Immunol Rev. 2011;241(1):241\u201359. doi: 10.1111\/j.1600-065X.2011.01017.x .","journal-title":"Immunol Rev"},{"issue":"3","key":"130_CR21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cyto.2008.10.012","volume":"44","author":"RD Muller","year":"2008","unstructured":"Muller RD, John T, Kohl B, Oberholzer A, Gust T, Hostmann A, et al. IL-10 overexpression differentially affects cartilage matrix gene expression in response to TNF-alpha in human articular chondrocytes in vitro. Cytokine. 2008;44(3):377\u201385. doi: 10.1016\/j.cyto.2008.10.012 .","journal-title":"Cytokine"},{"issue":"12","key":"130_CR22","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.joca.2007.04.011","volume":"15","author":"JA Roman-Blas","year":"2007","unstructured":"Roman-Blas JA, Stokes DG, Jimenez SA. Modulation of TGF-beta signaling by proinflammatory cytokines in articular chondrocytes. Osteoarthritis Cartilage. 2007;15(12):1367\u201377. doi: 10.1016\/j.joca.2007.04.011 .","journal-title":"Osteoarthritis Cartilage"},{"issue":"7","key":"130_CR23","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.joca.2012.04.002","volume":"20","author":"ME Meegeren van","year":"2012","unstructured":"van Meegeren ME, Roosendaal G, Jansen NW, Wenting MJ, van Wesel AC, van Roon JA, et al. IL-4 alone and in combination with IL-10 protects against blood-induced cartilage damage. Osteoarthritis Cartilage. 2012;20(7):764\u201372. doi: 10.1016\/j.joca.2012.04.002 .","journal-title":"Osteoarthritis Cartilage"},{"issue":"8","key":"130_CR24","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.joca.2012.04.008","volume":"20","author":"JP Vijven Van","year":"2012","unstructured":"Van Vijven JP, Luijsterburg PA, Verhagen AP, van Osch GJ, Kloppenburg M, Bierma-Zeinstra SM. Symptomatic and chondroprotective treatment with collagen derivatives in osteoarthritis: a systematic review. Osteoarthritis Cartilage. 2012;20(8):809\u201321. doi: 10.1016\/j.joca.2012.04.008 .","journal-title":"Osteoarthritis Cartilage"},{"key":"130_CR25","first-page":"CD002946","volume":"2","author":"TE Towheed","year":"2005","unstructured":"Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2005;2:CD002946. doi: 10.1002\/14651858.CD002946.pub2 .","journal-title":"Cochrane Database Syst Rev."},{"key":"130_CR26","first-page":"CD005614","volume":"1","author":"JA Singh","year":"2015","unstructured":"Singh JA, Noorbaloochi S, MacDonald R, Maxwell LJ. Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015;1:CD005614. doi: 10.1002\/14651858.CD005614.pub2 .","journal-title":"Cochrane Database Syst Rev."},{"issue":"11","key":"130_CR27","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jama.283.11.1469","volume":"283","author":"TE McAlindon","year":"2000","unstructured":"McAlindon TE, LaValley MP, Gulin JP, Felson DT. Glucosamine and chondroitin for treatment of osteoarthritis: a systematic quality assessment and meta-analysis. JAMA. 2000;283(11):1469\u201375.","journal-title":"JAMA"},{"issue":"8","key":"130_CR28","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa052771","volume":"354","author":"DO Clegg","year":"2006","unstructured":"Clegg DO, Reda DJ, Harris CL, Klein MA, O'Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis. N Engl J Med. 2006;354(8):795\u2013808. doi: 10.1056\/NEJMoa052771 .","journal-title":"N Engl J Med"},{"key":"130_CR29","doi-asserted-by":"crossref","unstructured":"Hochberg MC, Martel-Pelletier J, Monfort J, Moller I, Castillo JR, Arden N et al. Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib. Ann Rheum Dis. 2015. doi: 10.1136\/annrheumdis-2014-206792 .","DOI":"10.1136\/annrheumdis-2014-206792"},{"issue":"2","key":"130_CR30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/1759720X12467868","volume":"5","author":"J Sokolove","year":"2013","unstructured":"Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis. 2013;5(2):77\u201394. doi: 10.1177\/1759720X12467868 .","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"11","key":"130_CR31","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1136\/ard.2005.051292","volume":"65","author":"ML Andersson","year":"2006","unstructured":"Andersson ML, Petersson IF, Karlsson KE, Jonsson EN, Mansson B, Heinegard D, et al. Diurnal variation in serum levels of cartilage oligomeric matrix protein in patients with knee osteoarthritis or rheumatoid arthritis. Ann Rheum Dis. 2006;65(11):1490\u20134. doi: 10.1136\/ard.2005.051292 .","journal-title":"Ann Rheum Dis"},{"key":"130_CR32","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/1471-2474-7-98","volume":"7","author":"ML Andersson","year":"2006","unstructured":"Andersson ML, Thorstensson CA, Roos EM, Petersson IF, Heinegard D, Saxne T. Serum levels of cartilage oligomeric matrix protein (COMP) increase temporarily after physical exercise in patients with knee osteoarthritis. BMC Musculoskelet Disord. 2006;7:98. doi: 10.1186\/1471-2474-7-98 .","journal-title":"BMC Musculoskelet Disord."},{"issue":"8","key":"130_CR33","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1002\/art.21977","volume":"54","author":"SY Kong","year":"2006","unstructured":"Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB. Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis. Arthritis Rheum. 2006;54(8):2496\u2013504. doi: 10.1002\/art.21977 .","journal-title":"Arthritis Rheum"},{"issue":"3","key":"130_CR34","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/art.10822","volume":"48","author":"JM Jordan","year":"2003","unstructured":"Jordan JM, Luta G, Stabler T, Renner JB, Dragomir AD, Vilim V, et al. Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project. Arthritis Rheum. 2003;48(3):675\u201381. doi: 10.1002\/art.10822 .","journal-title":"Arthritis Rheum"},{"issue":"Pt 1","key":"130_CR35","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1469-7793.1999.287ad.x","volume":"515","author":"K Ostrowski","year":"1999","unstructured":"Ostrowski K, Rohde T, Asp S, Schjerling P, Pedersen BK. Pro- and anti-inflammatory cytokine balance in strenuous exercise in humans. J Physiol. 1999;515(Pt 1):287\u201391.","journal-title":"J Physiol"},{"issue":"6","key":"130_CR36","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/jor.22297","volume":"31","author":"Y Henrotin","year":"2013","unstructured":"Henrotin Y, Chevalier X, Deberg M, Balblanc JC, Richette P, Mulleman D, et al. Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO(2) ) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: a research study part of the Biovisco study. J Orthop Res. 2013;31(6):901\u20137. doi: 10.1002\/jor.22297 .","journal-title":"J Orthop Res"}],"container-title":["Nutrition Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12937-016-0130-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T04:45:27Z","timestamp":1498279527000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nutritionj.com\/content\/15\/1\/14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["130"],"URL":"https:\/\/doi.org\/10.1186\/s12937-016-0130-8","relation":{},"ISSN":["1475-2891"],"issn-type":[{"value":"1475-2891","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"14"}}